Kezar Life Sciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/10/2025 | 720.79 K | $2.81 M | 13.48% | 9.86% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 720.00 K | $2.81 M | 0.00% | 9.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 716.76 K | $2.80 M | 0.00% | 9.80% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 383.18 K | $1.49 M | 125.59% | 5.24% |
| VANGUARD GROUP INC | 11/07/2025 | 268.17 K | $1.05 M | -2.92% | 3.67% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 192.70 K | $751.53 K | 0.00% | 2.64% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 133.53 K | $519.00 K | 0.00% | 1.83% |
| PEAPOD LANE CAPITAL LLC | 11/10/2025 | 125.77 K | $490.54 K | 9.25% | 1.72% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 124.97 K | $487.37 K | -15.22% | 1.71% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 115.89 K | $451.95 K | 32.77% | 1.59% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 106.90 K | $416.91 K | 0.00% | 1.46% |
| BLACKROCK, INC. | 11/12/2025 | 98.10 K | $382.60 K | 0.44% | 1.34% |
| QIMING U.S. VENTURES MANAGEMENT, LLC | 11/10/2025 | 82.87 K | $323.20 K | 0.00% | 1.13% |
| SHAY CAPITAL LLC | 11/14/2025 | 67.66 K | $263.88 K | 0.00% | 0.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 65.50 K | $255.52 K | 0.59% | 0.90% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 54.26 K | $211.62 K | -0.70% | 0.74% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 41.00 K | $159.90 K | 0.00% | 0.56% |
| RBF CAPITAL, LLC | 11/14/2025 | 28.25 K | $110.19 K | 0.00% | 0.39% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 23.68 K | $92.36 K | -4.83% | 0.32% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 23.23 K | $90.60 K | -22.49% | 0.32% |
| STATE STREET CORP | 11/14/2025 | 21.09 K | $82.26 K | 0.00% | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 20.90 K | $81.51 K | 0.00% | 0.29% |
| CITADEL ADVISORS LLC | 11/14/2025 | 18.22 K | $71.06 K | 100.00% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2025 | 15.70 K | $61.23 K | 100.00% | 0.21% |
| NORTHERN TRUST CORP | 11/14/2025 | 13.94 K | $54.37 K | 0.00% | 0.19% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/13/2025 | 13.04 K | $50.86 K | 100.00% | 0.18% |
| FMR LLC | 11/13/2025 | 8.73 K | $34.06 K | -61.47% | 0.12% |
| MORGAN STANLEY | 11/14/2025 | 7.82 K | $30.50 K | -10.04% | 0.11% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 5.85 K | $22.80 K | 1.74% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.19 K | $4.63 K | 718.62% | 0.02% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 1.00 K | $3.90 K | 0.00% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 356 | $1.39 K | 768.29% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 209 | $815 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 121 | $472 | -32.78% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 100 | $390 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 96 | $374 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 90 | $323 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 51 | $199 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 1 | $4 | 100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kezar Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 56 institutional investors and hedge funds held shares of Kezar Life Sciences, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 720,787
TANG CAPITAL MANAGEMENT LLC: 720,000
SUVRETTA CAPITAL MANAGEMENT, LLC: 716,759
Stonepine Capital Management, LLC: 383,182
VANGUARD GROUP INC: 268,166
ORBIMED ADVISORS LLC: 192,700
57.53% of Kezar Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.52 M shares in the last 24 months. This purchase volume represents approximately $47.00 M in transactions.